Blood Biomarkers Predict Survival Outcomes in Patients with Hepatitis B Virus-Induced Hepatocellular Carcinoma Treated with PD-1 Inhibitors

Table 4

Multivariate Cox proportional hazards regression models for progression-free survival.

Variable	Multivariate analysis
	HR	95% CI	value
Child-Pugh class
B vs. A	0.963	0.236-3.935	0.958
CNLC stage
IIIb vs. IIb and IIIa	3.337	0.706-15.759	0.128
AFP
≥400 vs. <400 ng/ml	1.462	0.516-4.138	0.475
PVTT
Yes vs. none	17.972	2.216-145.779	0.007
PLR
≥140vs. <140	4.995	1.614-15.463	0.005